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a b s t r a c t
Inﬂuenza A viruses cause respiratory infections that range from asymptomatic to deadly in humans.
Widespread outbreaks (pandemics) are attributable to ‘novel’ viruses that possess a viral hemagglutinin
(HA) gene to which humans lack immunity. After a pandemic, these novel viruses form stable virus
lineages in humans and circulate until they are replaced by other novel viruses. The factors and
mechanisms that facilitate virus transmission among hosts and the establishment of novel lineages are
not completely understood, but the HA and basic polymerase 2 (PB2) proteins are thought to play
essential roles in these processes by enabling avian inﬂuenza viruses to infect mammals and replicate
efﬁciently in their new host. Here, we summarize our current knowledge of the contributions of HA, PB2,
and other viral components to virus transmission and the formation of new virus lineages.
& 2015 Elsevier Inc. All rights reserved.
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such novel viruses. The loss of life and economic costs are considerable
during annual inﬂuenza virus epidemics, and can be tremendous during
worldwide outbreaks of novel strains (pandemics). Pandemics may also
cause heightened public apprehension, resulting in the disruption of
daily life. In addition to the impact on human health, outbreaks of
inﬂuenza viruses can also cause considerable losses to the poultry, swine,
and race horse industries.
The Orthomyxoviridae family of viruses comprises ﬁve genera,
but only two are of medical relevance in humans, namely,
inﬂuenza A and B viruses. Inﬂuenza A viruses are further divided
into subtypes, based on the antigenic properties of the surface
glycoproteins hemagglutinin (HA) and neuraminidase (NA), the
two major viral antigens. Wild waterfowl are believed to be the
reservoir of inﬂuenza A viruses of the H1–H16 HA and the N1–N9
NA subtypes. To date, genetic material of inﬂuenza viruses of the
H17N10 and H18N11 subtypes has been detected only in bats
(Tong et al., 2012, 2013). From their natural reservoir, inﬂuenza A
viruses can be transmitted to numerous other species, primarily
poultry, pigs, and humans. In humans, only viruses of the H1N1,
H2N2, and H3N2 subtypes have circulated for extended periods.
Avian inﬂuenza viruses of the H5N1 and H7N9 subtypes have
infected hundreds of people since their emergence in 1997 and
2013, respectively, but have failed to spread efﬁciently among
humans. In addition, there have been reports of isolated cases of
human infections with viruses of several other subtypes, namely
H9N2, H6N1, H7N7, H10N8, H7N2, and H7N3 (Arzey et al., 2012;
Peiris et al., 1999; Yuan et al., 2013; Chen et al., 2014; Ostrowsky
et al., 2012; Lopez-Martinez et al., 2013; Fouchier et al., 2004;
Koopmans et al., 2004).
The inﬂuenza virus life cycle is initiated by the binding of viral
HA to receptors on host cells. After endocytosis and HA-mediated
fusion of the viral and cellular membranes, viral ribonucleoprotein
complexes are released into the cytoplasm, transported to the nucleus,
and replicated and transcribed by the viral polymerase complex.
Newly formed viral ribonucleoprotein complexes and structural pro-
teins are transported to the plasma membrane, where the new viruses
are formed and bud (a detailed description of the viral life cycle can be
found in reference (Shaw and Palese, 2013).
We do not yet have a complete understanding of the factors
and mechanisms that are essential for inﬂuenza virus transmis-
sion, cause pandemics, and lead to the establishment of novel
lineages. In the broadest terms, inﬂuenza virus evolution is driven
by two mechanisms: mutations in the viral genome, and reassort-
ment, which is the rearrangement of the eight inﬂuenza A viral
RNA (vRNA) segments in cells infected with at least two different
viruses. Here, we review how these mechanisms affect the
transmissibility of inﬂuenza A viruses.
Establishment of novel inﬂuenza A virus lineages in humans
In 1918, a novel inﬂuenza A virus that transmitted efﬁciently
among humans caused a pandemic of unparalleled scale, killing an
estimated 50–100 million people worldwide. Taubenberger and
colleagues reconstituted the sequence of this pandemic virus from
historic samples (reviewed in (Taubenberger et al., 2012)). Based
on the analysis of the viral sequences, the pandemic virus most
likely originated from an avian host. Descendants of the pandemic
virus formed a new virus lineage in humans and circulated until
1957, when they were replaced by a novel inﬂuenza virus of the
H2N2 subtype, which caused the ‘Asian’ inﬂuenza. This virus was a
reassortant with HA, NA, and polymerase PB1 vRNA segments
derived from an avian inﬂuenza virus, and the remaining ﬁve
vRNA segments originating from the previously circulating H1N1
viruses. This novel virus became established in human populations
and circulated for the next decade. In 1968, another reassortant
virus caused the ‘Hong Kong’ inﬂuenza. It possessed six vRNA
segments from the previously circulating H2N2 viruses, whereas
its HA and PB1 vRNA segments were derived from avian H3
inﬂuenza viruses. After causing a pandemic, the novel H3N2
viruses became established in humans and are still circulating in
human populations to this day. In 1977, H1N1 viruses closely
related to those circulating in humans in the 1950 s reemerged;
the origin of these reemerged viruses is unknown. The H1N1
viruses again formed a stable lineage in humans and co-circulated
with human H3N2 viruses until they were replaced by a novel
pandemic H1N1 virus in 2009. This most recent pandemic resulted
from multiple reassortment events, which most likely occurred in
pigs: in the late 1990s, novel ‘triple reassortant’ H1N2 viruses
emerged in North American pigs. These viruses possessed PB2 and
PA polymerase vRNA segments derived from avian inﬂuenza
viruses; nucleoprotein (NP), matrix (M), and nonstructural (NS)
vRNA segments derived from previously circulating H1N1 swine
inﬂuenza viruses; and HA, NA, and PB1 vRNA segments derived
from human inﬂuenza viruses (Karasin et al., 2000; Olsen, 2002;
Webby et al., 2000; Zhou et al., 1999). These ‘triple reassortant’
viruses caused sporadic infections (Bastien et al., 2010; Cox et al.,
2011; Olsen et al., 2006; Shinde et al., 2009) but did not become
adapted to humans. In 2009, however, the NA and M vRNA
segments of a Eurasian avian-like swine virus reassorted with
the remaining six vRNA segments of the ‘triple reassortant’ swine
viruses, resulting in the 2009 pandemic H1N1 virus (reviewed in
(Neumann et al., 2009)). This virus has now established a stable
lineage in humans and currently co-circulates with human H3N2
inﬂuenza viruses.
Sporadic infections of humans with swine or avian inﬂuenza
viruses
In 1976, a classic H1N1 swine virus was isolated from ﬁve
soldiers at Fort Dix, New Jersey, USA (Gaydos et al., 1977; Goldﬁeld
et al., 1977; Hodder et al., 1977; Kendal et al., 1977). Serological
studies demonstrated that more than 500 people had been
infected with this virus (Gaydos et al., 1977; Hodder et al., 1977;
Dowdle and Millar, 1978), suggesting that it was capable of
human-to-human transmission. Yet, this virus did not establish a
stable lineage in humans. Since August 2011, more than 340
people in North America have been infected with so-called
‘H3N2v’ (H3N2 variant) swine viruses. These viruses share the M
vRNA segment with 2009 pandemic H1N1 viruses, but possesses
HA and NA vRNA segments derived from human H3N2 viruses that
were introduced into pigs in the mid-1990s (Kitikoon et al., 2012;
Nelson et al., 2012; Ducatez et al., 2011; Liu et al., 2012).
Epidemiological data suggest pigs as the likely source of human
H3N2v infections. Most reported cases have been in children,
presumably because they were not infected with the human H3N2
viruses that circulated in the mid-1990s and therefore lacked
protective immunity against them. No sustained human-to-
human transmission of this virus has been reported to date.
Generally, infections of humans with avian inﬂuenza viruses
are rare; however, in recent years, avian inﬂuenza A viruses of the
H5N1 and H7N9 subtypes have infected hundreds of people with
case fatality rates of 60% and 30%, respectively.
The transmission of highly pathogenic avian H5N1 viruses to
humans was ﬁrst reported in 1997 in Hong Kong (Claas et al.,
1998a, 1998b; Subbarao et al., 1998). The culling of birds in live
poultry markets in Hong Kong brought a temporary end to the
human infections, but new cases were reported in 2003. Since
then, highly pathogenic avian H5N1 inﬂuenza viruses have spread
across three continents, have become enzootic in poultry popula-
tions in parts of Southeast Asia, the Middle East, and perhaps also
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Indonesia, and have infected 694 people as of January 6, 2015, 492
(71%) of whom died (http://www.who.int/inﬂuenza/human_ani
mal_interface/EN_GIP_20150106CumulativeNumberH5N1cases.
pdf?ua=1). Isolated cases of suspected human-to-human trans-
mission have been reported, but sustained transmission chains in
humans—which could lead to a pandemic—have not occurred.
Infections of humans with inﬂuenza viruses of the H7 subtype
are typically self-limiting and associated with conjunctivitis and/or
mild respiratory disease (reviewed in (Belser et al., 2009)),
although a fatal human infection with an H7N7 virus occurred in
2003 in the Netherlands (Fouchier et al., 2004; Koopmans et al.,
2004). Since the spring of 2013, however, more than 450 human
infections with a novel inﬂuenza virus of the H7N9 subtype have
been documented. Epidemiologic and genetic data suggest poultry
as the likely source of these infections. The internal genes of the
H7N9 virus closely resemble those of H9N2 poultry viruses that
have been circulating in China in recent years; the H7 HA and N9
NA vRNA segments most likely originated from H7 viruses circu-
lating in ducks in southern China in 2010 and 2011, and from duck
or wild bird N9 viruses, respectively (China—WHO Joint Mission
on Human Infection with Avian Inﬂuenza A(H7N9), 2013; Centers
for Disease C, Prevention, 2013; Chen et al., 2013; Gao et al., 2013;
Kageyama et al., 2013; Lam et al., 2013; Liu et al., 2013; Shi et al.,
2013; Wu et al., 2013). Thus, the H7N9 viruses were most likely
created by several reassortment events among avian viruses. To
date, no sustained transmission of H7N9 viruses among humans
has been reported.
The role of HA receptor-binding speciﬁcity in inﬂuenza A virus
transmission
Infections of humans with avian or swine inﬂuenza viruses
occur sporadically, but typically do not result in the establishment
of new lineages. Numerous studies over the last few decades have
identiﬁed the viral HA protein as the major host restriction factor
that limits interspecies transmission and the establishment of
virus lineages in new hosts.
Inﬂuenza viruses bind to sialyloligosaccharides on glycopro-
teins or glycolipids on the surface of host cells to infect them. Sialic
acids can be linked to the penultimate galactose through different
linkages, such as an α2,3- or an α2,6-linkage (Siaα2,3Gal or
Siaα2,6Gal). The epithelial cells in the duck intestine express
primarily Siaα2,3Gal (Ito and Kawaoka 2000), and inﬂuenza A
viruses circulating in wild waterfowl efﬁciently bind to this type of
sialic acid (Rogers and Paulson 1983; Rogers et al., 1983). By
contrast, epithelial cells in the human trachea contain predomi-
nately Siaα2,6Gal, whereas Siaα2,3Gal is found on certain alveolar
cells (Couceiro et al., 1993; Matrosovich et al., 2004; Shinya et al.,
2006; Baum and Paulson 1990; Nicholls et al., 2007; Yao et al.,
2008; van Riel et al., 2006). Inﬂuenza viruses circulating in
humans have therefore adapted to bind efﬁciently to Siaα2,6Gal
(Matrosovich et al., 2000). The epithelial cells of the pig trachea
contain both Siaα2,3Gal and Siaα2,6Gal (Ito et al., 1998; Nelli et al.,
2010; Trebbien et al., 2011), which may explain why pigs can be
infected efﬁciently by human and avian inﬂuenza viruses; conse-
quently, pigs may serve as ‘mixing vessels’ for the reassortment of
avian, swine, and human inﬂuenza viruses, an event that likely led
to the pandemic of 2009. Both types of sialic acid are also found on
epithelial cells in the gastrointestinal and respiratory tract of
chickens and other terrestrial poultry (Costa et al., 2012), consis-
tent with the ﬁnding that inﬂuenza viruses isolated from terres-
trial poultry can have dual avian/human-type receptor-binding
speciﬁcity.
For this reason, it has been proposed that terrestrial poultry
may be an intermediate host, facilitating the adaptation of avian
inﬂuenza viruses to mammals.
Receptor-binding speciﬁcity and transmissibility of H1 inﬂuenza
viruses
For H1 HAs, the amino acids at two positions, 190 and 225,
deﬁne the binding preference for Siaα2,3Gal or Siaα2,6Gal
(Matrosovich et al., 2000; Glaser et al., 2005); note that all HA
amino acid positions listed in this paper refer to the numbering
scheme of H3 HA as described by Burke and Smith, (2014).
Glutamic acid and glycine at these positions confer efﬁcient
binding to avian-type receptors, whereas aspartic acid at these
positions allows efﬁcient binding to Siaα2,6Gal. The A/South
Carolina/1/1918 (H1N1) pandemic virus encodes the human-type
residues at positions 190 and 225 of its HA protein (i.e., HA-190D,
HA-225D), bound to Siaα2,6Gal (Glaser et al., 2005), and trans-
mitted efﬁciently via respiratory droplets among ferrets (Tumpey
et al., 2007); resolution of its crystal structure provided further
insights into its human-type receptor-binding preference
(Gamblin et al., 2004). By contrast, the HA protein of A/New
York/1/1918 pandemic virus (encoding the human-type HA-190D
and avian-type HA-225G residues) bound to both Siaα2,6Gal and
Siaα2,3Gal (Glaser et al., 2005); this virus transmitted less efﬁ-
ciently via respiratory droplets in ferrets than did A/South Car-
olina/1/18 virus (Tumpey et al., 2007). A mutant 1918 HA with the
avian-type HA-190E and HA-225G residues displayed avian-type
receptor-binding speciﬁcity (Glaser et al., 2005) and did not
facilitate transmission among ferrets (Tumpey et al., 2007). Hence,
Van Hoeven et al. (2009) asked whether 1918 pandemic viral
genes could confer respiratory droplet transmissibility to an avian
inﬂuenza virus that typically lacks this property. They found that
the HA gene of the 1918 pandemic virus alone was not sufﬁcient to
confer virus transmissibility in ferrets; the PB2 gene of the 1918
pandemic virus was also needed.
Recently, Watanabe et al. (2014) generated a ‘1918-like avian’
virus composed of avian inﬂuenza vRNA segments with high
homology to the 1918 pandemic virus. This ‘1918-like avian’ virus
was more pathogenic in mice and in ferrets than a natural avian
inﬂuenza virus but did not transmit via respiratory droplets
among ferrets (Watanabe et al., 2014). However, a mutant variant
of this virus possessing seven mutations in its HA and polymerase
proteins (namely, HA-E89D, –S113N, –E190D, –G225D; PB2-E627K,
–A684D; PA-V253M) transmitted among ferrets via respiratory
droplets (Watanabe et al., 2014). The HA-E190D/G225D and PB2-
E627K changes were introduced to confer human-type receptor-
binding speciﬁcity (see above) and efﬁcient replication in mam-
mals (see ‘The Role of Polymerase Proteins in Inﬂuenza A Virus
Transmission’), whereas the other mutations emerged during virus
ampliﬁcation in cell culture or replication in ferrets. This study
demonstrated that contemporary avian inﬂuenza viruses encoding
viral proteins similar to those of the 1918 pandemic virus may
acquire the ability to transmit among mammals; moreover, this
study again demonstrated the important role of HA and PB2 in
virus transmissibility.
The HA proteins of the 2009 pandemic H1N1 viruses encode
human-type amino acids at positions 190 and 225 and bind
primarily to Siaα2,6Gal (Maines et al., 2009; Yang et al., 2010; Xu
et al., 2010), although one study reported that these viruses have
dual avian/human-type receptor-binding speciﬁcity (Childs et al.,
2009). X-ray crystallographic analysis of 2009 pandemic H1N1
virus HA proteins has provided a structural explanation for
human-type receptor-binding speciﬁcity (Yang et al., 2010;
Zhang et al., 2010). Consistent with their human-type receptor-
binding speciﬁcity, 2009 pandemic H1N1 viruses transmitted
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efﬁciently among ferrets and guinea pigs in direct contact and
respiratory droplet transmission models (Neumann et al., 2009;
Itoh et al., 2009; Steel et al., 2010a, 2011, 2010b). Some 2009
pandemic H1N1 viruses encode the avian virus-type glycine
residue at position 225, which confers dual avian/human-type
receptor-binding speciﬁcity and appears to correlate with
increased severity of disease (Kilander et al., 2010; Mak et al.,
2010; Glinsky 2010; Potdar et al., 2010; Miller et al., 2010; Anton
et al., 2010; Chen et al., 2010; Preliminary 2010; Chutinimitkul
et al., 2010). However, this mutation has not increased in fre-
quency, suggesting that viruses that carry it do not transmit
efﬁciently among humans.
Receptor-binding speciﬁcity and transmissibility of H7 inﬂuenza
viruses
The human-type receptor-binding speciﬁcity of H3 HAs is
conferred by leucine and serine at positions 226 and 228, in
contrast to glutamine and glycine at these positions, which
facilitate efﬁcient binding to avian-type receptors (Matrosovich
et al., 2000; Connor et al., 1994; Naeve et al., 1984). H3 and H7 HAs
are phylogenetically closely related, suggesting that the amino
acids at position 226 and 228 may also determine the receptor-
binding speciﬁcity of H7 inﬂuenza viruses. The H7N7 inﬂuenza
virus isolated from the fatal case in the Netherlands in 2003 (A/
Netherlands/219/2003, H7N7) encoded avian-type amino acids at
positions 226 and 228, displayed avian-type receptor-binding
speciﬁcity (Belser et al., 2008) and did not transmit among ferrets
(Belser et al., 2008). A virus isolated during the same outbreak
from a person who developed conjunctivitis (A/Netherlands/230/
2003, H7N7) was transmitted to cage mates (Belser et al., 2012);
the HA proteins of these two viruses differ by three amino acids,
but their contribution to transmissibility is currently unknown.
Some North American H7 viruses display increased binding to
human-type receptors and/or transmit to co-housed ferrets, but
not to animals in adjacent cages (Belser et al., 2008, 2012, 2013;
Gambaryan et al., 2012).
The H7N9 viruses that emerged in China in 2013 encode
human virus-type leucine at position 226, but the avian-type
amino acid at position 228. Most H7N9 viruses also encode valine
at HA position 186, which is known to affect the receptor-binding
speciﬁcity of H7 HAs (Gambaryan et al., 2012; Yang et al., 2013;
Srinivasan et al., 2013). One H7N9 isolate (A/Shanghai/1/2013)
encodes HA-138S, which increases the binding of pig H5N1
inﬂuenza viruses to Siaα2,6Gal (Nidom et al., 2010). It is, therefore,
not surprising that the H7N9 viruses bind to both Siaα2,3Gal and
Siaα2,6Gal, although differences have been reported depending on
the isolate and the nature of the sample (i.e., puriﬁed HA protein
or whole virus) (Ramos et al., 2013; van Riel et al., 2013; Shi et al.,
2013; Watanabe et al., 2013; Xiong et al., 2013; Zhou et al., 2013;
Tharakaraman et al., 2013). The X-ray crystallographic structure of
A/Anhui/1/2013 HA has been solved in complex with human- and
avian-type receptors (Shi et al., 2013; Xiong et al., 2013): the
human virus-type HA-226L residue creates a non-polar binding
site for the human-type receptor, whereas HA-186V increases the
hydrophobicity of the binding site. However, the orientation of the
human-type receptor in the binding pocket differed from that
observed for pandemic viruses and an H5 HA virus that conferred
transmissibility in humans.
The dual avian/human virus receptor-binding speciﬁcity of
H7N9 viruses likely explains their respiratory droplet transmissi-
bility, although these viruses transmit less efﬁciently than human
inﬂuenza viruses (Watanabe et al., 2013; Xu et al., 2014; Yen et al.,
2014; Richard et al., 2013; Zhang et al., 2013; Belser et al., 2013;
Zhu et al., 2013). In guinea pigs, efﬁcient contact transmission to
cage mates (Gabbard et al., 2014) and respiratory droplet
transmission (Hai et al., 2013) have been detected. By contrast,
no H7N9 virus transmission occurred between pigs and ferrets in
an experimental setting (Zhu et al., 2013). Sequential passages of
H7N9 viruses in ferrets did not increase the respiratory droplet
transmissibility of H7N9 viruses (Richard et al., 2013). A single
passage of an avian H7N9 virus (A/chicken/Zhejiang/DTID-ZJU01/
2013) in pigs resulted in a virus with mutations in the HA, NA, M,
and NS vRNA segments, which conferred enhanced binding to
human-type receptors and high virus titers in the lungs of infected
pigs (Xu et al., 2014); by contrast, three consecutive passages of
the human A/Anhui/1/2013 (H7N9) virus in pigs did not increase
virus titers or the preference for human-type receptors (Xu et al.,
2014). These ﬁndings demonstrate that H7 inﬂuenza viruses
already have the capability to transmit among mammals, which
demonstrates their pandemic potential; even so, only two family
clusters of human-to-human transmission of H7N9 viruses have been
reported to date (Liu et al., 2014; Qi et al., 2013). These studies also
suggest that H7N9 virus passages in mammals do not readily result in
highly virulent and/or mammalian-transmissible viruses.
In another study, a highly pathogenic H7N1 virus (A/ostrich/
Italy/2332/2000) underwent 10 serial passages in ferrets (Sutton
et al., 2014). The wild-type isolate possessed avian-type receptor-
binding speciﬁcity (Gambaryan et al., 2012) but encoded the
mammalian-adapting PB2-627K mutation (see ‘The Role of Poly-
merase Proteins in Inﬂuenza A Virus Transmission’). Serial pas-
sages in ferrets resulted in the selection of a variant that
transmitted to other ferrets via contact and respiratory droplet
transmission (Sutton et al., 2014). The transmissible variant
possessed ﬁve additional amino acid changes in its PB2 (T81I),
NP (V284M), M1 (R95K, Q211K), and HA (K/R304R) proteins. The
mutation in HA localizes to the stalk region and may affect the
stability of the protein (see ‘The Role of HA Stability in Inﬂuenza A
Virus Transmission).
Receptor-binding speciﬁcity and transmissibility of H5 inﬂuenza
viruses
Most highly pathogenic avian H5N1 viruses, including those
isolated from humans, bind to Siaα2,3Gal, but not to Siaα2,6Gal
((Matrosovich et al., 1999); reviewed in (Watanabe et al., 2012));
this binding preference is consistent with the structural analysis of
an H5 HA (Stevens et al., 2006). The avian-type receptor-binding
speciﬁcity of H5 HAs may explain why these viruses have not
acquired the ability to transmit among humans. However, several
H5N1 viruses isolated from infected people (Auewarakul et al.,
2007; Kongchanagul et al., 2008; Yen et al., 2007) and recent avian
isolates from Egypt (Watanabe et al., 2011) bind somewhat to
Siaα2,6Gal, while maintaining their ability to binding to Siaα2,3-
Gal. Several natural or experimentally introduced amino acid
changes in HA (namely, N186K, E190D, K193R, Q226L, S227N,
and G228S) increased binding to Siaα2,6Gal or decreased binding
to Siaα2,3Gal (Stevens et al., 2006; Auewarakul et al., 2007;
Watanabe et al., 2011; Chutinimitkul et al., 2010; Maines et al.,
2011; Stevens et al., 2008; Ayora-Talavera et al., 2009). Another
study revealed that mutations that affected the receptor-binding
speciﬁcity of H1 HA (i.e., those at positions 190 and 225) did not
confer human-type receptor-speciﬁcity to H5 HA; in contrast,
mutations at positions 226 and 288 (which affect H3 HA
receptor-binding speciﬁcity) resulted in an H5 HA that bound to
a human-type receptor-analog (Stevens et al., 2006).
Several studies have tested the transmissibility of highly
pathogenic avian H5N1 inﬂuenza viruses in animal models,
including isolates obtained from humans. The human H5N1 isolate
A/Vietnam/1203/2004 (VN1203) did not transmit among mice (an
animal model in which inﬂuenza viruses typically do not transmit)
in the same cage (Lowen et al., 2006). Seroconversion or infection
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of ferret cage mates was reported for two different H5N1 viruses,
one of which also showed limited binding to human-type recep-
tors (A/Hong Kong/213/2003) (Yen et al., 2007); however, virus
transmission via respiratory droplets was not assessed in this
study. Studies with several H5N1 viruses have demonstrated a lack
of respiratory droplet transmission among ferrets (Maines et al.,
2006; Herfst et al., 2012; Imai et al., 2012; Chen et al., 2012),
although seroconversion was reported for two of three animals
housed adjacent to ferrets inoculated with A/Hong Kong/486/1997
(Maines et al., 2006).
H5N1 inﬂuenza viruses reassort readily with human H3N2 or
2009 pandemic H1N1 viruses in experimental settings (Chen et al.,
2008; Li et al., 2010; Zhang et al., 2013). Several studies have,
therefore, tested the transmissibility in mammals of avian H5N1/
human reassortant viruses (Maines et al., 2006; Zhang et al., 2013;
Jackson et al., 2009). Maines et al. (2006) found that a virus
possessing the HA and NA genes of an efﬁciently transmitting
human H3N2 virus and the remaining genes from an H5N1 virus
did not efﬁciently transmit via respiratory droplets, although one
contact animal sero-converted. Similarly, the six internal genes (or
the three polymerase and NP genes) of the human H3N2 virus did
not confer respiratory droplet transmission in ferrets in combina-
tion with the HA and NA genes (or HA, NA, M, and NS genes) of the
H5N1 virus (Maines et al., 2006). The virus possessing the
polymerase and NP vRNA segments from the human H3N2 virus
and the HA, NA, M, and NS vRNA segments from the H5N1 virus
was then passaged ﬁve time in ferrets; yet, virus transmission
among ferrets was still not detected (Maines et al., 2006). Like-
wise, none of ﬁve avian H5N1/human H3N2 virus reassortants (all
possessing the H5 HA) transmitted to ferrets housed in the same
cage (Jackson et al., 2009). Schrauwen et al. (2013) infected ferrets
with a mixture of reassortant H5N1/2009 pandemic H1N1 viruses
(all possessing the H5 HA gene) and found a dominant population
of reassortants that carried the NA and M genes of 2009 pandemic
H1N1 viruses; no respiratory droplet transmission was detected
for these viruses (note, this ﬁnding may indicate a dominance of
the 2009 pandemic H1N1 NA and M vRNA segments over the NA
and M vRNA segments of previously circulating viruses). Likewise,
a reassortant virus possessing an H5 HA in the background of a
2009 pandemic H1N1 virus did not transmit to contact ferrets
Cline et al., 2011.
To determine whether the introduction of human-type amino
acids into the HA of H5N1 viruses confers respiratory droplet
transmissibility to these viruses in mammals, Maines et al. (2011)
generated several H5N1 viruses with mutations known to affect
receptor-binding speciﬁcity (including HA-E190D, –K193S, –
Q226L, and/or –G228S). Two mutants (encoding HA-226L/228S
or HA-187G/190D/193S/226L/228S) were able to recognize Siaα2,
6Gal in addition to Siaα2,3Gal (Maines et al., 2011). One mutant
(possessing the HA-R193K, –Q226L, and –G228S mutations) exhib-
ited a shift from avian- to human-type receptor-binding speciﬁ-
city; however, this shift did not result in virus transmission via
respiratory droplets in the ferret model (Maines et al., 2011).
In another study, Chen et al. (2012) demonstrated that three
mutations in HA (HA-Q196R, –Q226L, –G228S) conferred predo-
minant binding to Siaα2,6Gal; this mutant H5N1 virus was
transmitted to co-housed ferrets but not to animals placed in a
separate cage. However, a reassortant in which the avian H5N1-
derived N1 gene was replaced with an N2 gene of human virus
origin transmitted via respiratory droplets to one of two ferrets
housed in a separate cage; the infected ferret did not succumb to
the infection (Chen et al., 2012). This was the ﬁrst study that
resulted in a respiratory droplet-transmissible virus possessing an
H5 HA gene derived from a highly pathogenic avian H5N1
inﬂuenza virus.
Herfst et al. (2012) tested an H5N1 virus encoding the HA-
Q226L and –G228S mutations (known to confer efﬁcient binding
to human-type receptors), and the PB2-R627K mutation, which is
known to confer efﬁcient replication in mammals (see ‘The Role of
Polymerase Proteins in Inﬂuenza A Virus Transmission’); virus
transmission via respiratory droplets did not occur. However, after
ten consecutive passages of this virus in ferrets (in which nasal
turbinate or nasal wash samples obtained from infected animals
were used to inoculate the next set of ferrets), a variant was
isolated that transmitted via respiratory droplets among ferrets;
this virus was not lethal in ferrets. Three mutations (HA-H110Y
and –T160A; PB1-H99Y), in addition to those introduced deliber-
ately, were essential for the respiratory droplet transmissibility of
this virus among ferrets (Herfst et al., 2012; Linster et al., 2014).
By using an approach in which ‘virus libraries’ comprising a
large number of mutants that possessed random amino acid
changes in the globular head of their H5 HA were screened for
variants that efﬁciently bound to human-type receptors, we
isolated a mutant (possessing the HA-N224K and –Q226L muta-
tions) whose receptor-binding speciﬁcity shifted from Siaα2,3Gal
to Siaα2,6Gal binding (Imai et al., 2012). A reassortant possessing
the mutant HA together with the remaining seven vRNA segments
of A/California/04/2009 (a prototype human 2009 pandemic H1N1
virus) did not transmit to ferrets housed in adjacent cages, but
gained this function after two passages in ferrets (Imai et al.,
2012); all infected animals recovered from the infection. Two
additional mutations (HA-N158D and –T318I) were detected in
the HA of this ferret-transmissible virus (Imai et al., 2012).
Structural studies demonstrated that the mutations in the HA
proteins of the ferret-transmissible viruses isolated by Herfst et al.
(2012) and Imai et al. (2012) allowed H5 HA binding to Siaα2,6Gal
in a conformation similar to that observed for human H1, H2, and
H3 viruses (Xiong et al., 2013; Lu et al., 2013; Zhang et al., 2013). In
particular, Xiong et al. (2013) found that the orientation of
galactose and N-acetylglucosamine at positions 2 and 3 of the
sialic acid resemble those found for human viruses that interact
with human-type receptors; this orientation differs from that of
wild-type H5N1 HA interacting with a human-type receptor.
Studies in guinea pigs have shown that several H5N1 viruses
can transmit to co-housed animals (Steel et al., 2009; Gao et al.,
2009); the mutations HA-160A (which results in the loss of a
glycosylation site at positions 158–160 of HA; see ‘The Role of HA
Glycosylation in Inﬂuenza A Virus Transmission’) and PB2-627K or
PB2-701N (see ‘The Role of Polymerase Proteins in Inﬂuenza A
Virus Transmission’) are responsible for this feature. A study that
tested reassortants between a highly pathogenic avian H5N1 virus
(with dual avian/human receptor-binding speciﬁcity) and a human
2009 pandemic H1N1 virus found that the human virus PA or NS
gene conferred respiratory droplet transmissibility to the H5N1
virus in guinea pigs (Zhang et al., 2013); in addition, the NA and M
genes of the human virus contributed to the respiratory droplet
transmission in this animal model (Zhang et al., 2013).
Receptor-binding speciﬁcity and transmissibility of H9 inﬂuenza
viruses
Human infections with H9 inﬂuenza viruses have been infre-
quently reported (Peiris et al., 1999; Saito et al., 2001; Butt et al.,
2005), but epidemiological studies suggest that they may occur
more frequently than currently recognized (reviewed in (Li and
Chen, 2014)). Viruses of the H9 subtype circulate widely in poultry
and have also been isolated from pigs. Importantly, H9 viruses
have donated genes to the currently circulating H5N1 (Neumann
et al., 2010; Guan et al., 1999, 2004, 2002; Li et al., 2004; Duan
et al., 2008; Freidl et al., 2014) and H7N9 viruses (see ‘Sporadic
Infections of Humans with Swine or Avian Inﬂuenza Viruses’).
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Many Asian H9N2 viruses have acquired the HA-Q226L mutation,
which increases binding to human-type receptors (Matrosovich
et al., 2001; Wan and Perez, 2007). Nonetheless, several avian
H9N2 viruses tested did not transmit among ferrets via respiratory
droplets, although two of these viruses infected co-housed, naïve
animals (Wan et al., 2008). A reassortant possessing Asian H9N2
virus-derived HA (encoding HA-226L) and NA genes combined
with the internal genes of a human H3N2 virus transmitted to
ferret cage mates, but not via respiratory droplets to animals in
adjacent cages (Wan et al., 2008). However, after ten sequential
passages in ferrets, a virus was obtained that transmitted via
respiratory droplets (Sorrell et al., 2009). Three amino acid
changes in the surface glycoproteins (HA-T189A and –G510R, and
NA-I28V) were responsible for this change in transmissibility
(Sorrell et al., 2009). Based on this information, Kimble et al.
(2011) generated reassortants composed of 2009 pandemic H1N1
vRNA segments and the HA or HA/NA vRNA segments of the H9N2
ferret-transmissible virus, or the parent of the ferret-transmissible
virus. Three of four reassortant viruses transmitted via respiratory
droplets to naïve ferrets (Kimble et al., 2011), further demonstrat-
ing the potential of avian/human reassortants to transmit among
mammals via respiratory droplets.
Receptor-binding speciﬁcity and transmissibility of H6 inﬂuenza
viruses
Only few infections of humans with inﬂuenza viruses of the H6
subtype have been reported (reviewed in (Freidl et al., 2014));
however, the recent testing of 257 H6 viruses isolated in China
from 2008–2011 revealed that 87 of them bound to human-type
receptors (Wang et al., 2014). Many of these viruses replicated
efﬁciently in mice and ﬁve of ten viruses tested transmitted to co-
housed guinea pigs (Wang et al., 2014). Avian H6 viruses may thus
be capable of transmitting and adapting to humans.
This paragraph summarizes the entire section 3, not just 3.5.
Collectively, receptor-binding and transmission studies of H1, H5,
H6, H7, and H9 viruses established that HA receptor-binding
speciﬁcity plays a pivotal role in virus transmissibility. HA proteins
with avian-type receptor preference do not facilitate virus trans-
mission among ferrets. Viruses that bind to both avian- and
human-type cellular receptors may transmit among ferrets via
respiratory droplets, but the efﬁciency of transmission will likely
be low. A complete change from Siaα2,3Gal to Siaα2,6Gal binding
may be necessary (although not sufﬁcient) to allow efﬁcient
respiratory droplet transmission in ferrets, and perhaps humans.
This change in receptor-binding speciﬁcity may be important to
avoid virus binding to mucus in the respiratory tract of humans,
which predominantly contains Siaα2,3Gal (Couceiro et al., 1993;
Lamblin and Roussel 1993).
The role of HA glycosylation in inﬂuenza A virus transmission
Newly synthesized HA protein is inserted into the ER and
transported through the Golgi complex to the plasma membrane.
During its transport through the ER/Golgi network, HA is glycosy-
lated at asparagine residues of the N-x-S/T motif (N-glycosylation).
The number and location of glycosylation sites and oligosaccharide
side chains differ among inﬂuenza strains and subtypes (reviewed
in (Wright et al., 2013)). HA glycosylation affects a variety of
biological properties including antigenicity, virulence, receptor-
binding speciﬁcity, and receptor-binding afﬁnity (reviewed in
(Wright et al., 2013)). Glycosylation had not been linked to
inﬂuenza virus transmissibility until two key observations were
made: both ferret-transmissible H5 viruses isolated by Imai et al.
(2012) and Herfst et al. (2012) possessed mutations (HA-N158D
and HA-T160A, respectively) that resulted in the loss of the same
glycosylation site (i.e., the N-x-S/T glycosylation site at position
158–160 of HA). Moreover, the HAs of the ferret- and guinea pig-
transmissible H5 viruses described by Chen et al. (2012) and Zhang
et al. (2013) also lack a glycosylation site at position 158–160 of
HA. Thus, all four mammalian-transmissible H5 viruses described
to date lack this glycosylation site, suggesting that glycosylation at
this site may sterically interfere with virus binding to the cellular
receptor. This idea is supported by the ﬁndings that the loss of the
glycosylation site at HA position 158–160 results in increased
binding of H5N1 viruses to human-type receptors (Gao et al.,
2009; Wang et al., 2010), and in efﬁcient replication in the upper
respiratory tract of ferrets of H5N1 viruses possessing the HA-
Q226L or –Q226L/G228S mutations (Wang et al., 2010). Our
analysis of H5N1 virus sequences revealed that H5N1 viruses
isolated from humans in Egypt lack the glycosylation site at HA
158–160, whereas one-fourth of Egyptian avian H5N1 viruses
encode a glycosylation site at this position (Neumann et al.,
2012); this ﬁnding may suggest that H5N1 viruses without the
glycosylation site transmit more efﬁciently to humans than do
those with a glycosylation site at HA 158–160. In line with the
hypothesis, it is noteworthy that the HA proteins of the recently
emerged H7N9 viruses naturally lack the glycosylation site at HA
158–160, which may contribute to their ability to infect humans.
The role of HA stability in inﬂuenza A virus transmission
The ferret-transmissible virus isolated by Imai et al. (2012)
acquired an HA-T318I mutation during passage in ferrets. The
localization of this mutation in the stem region of HA suggested a
potential effect on HA stability which we, indeed, demonstrated
(Imai et al., 2012). The heat stability of HA is also associated with
the pH at which HA undergoes a conformational change that
triggers the fusion of the viral and endosomal membranes: in
inﬂuenza virus-infected cells, the low pH in late endosomes
triggers the conformational change in HA, but the energy barrier
for the conformational change can also be overcome by increased
temperatures.
The signiﬁcance of our ﬁnding that HA stability plays a role
in virus transmission became evident when we found that the
HA-N224K/Q226L mutations (which cause a change from human-
to avian-type receptor-binding speciﬁcity; see ‘Receptor-binding
speciﬁcity and transmissibility of H5 inﬂuenza viruses’) reduced
heat stability, which was restored by the HA-T318I mutation (Imai
et al., 2012). Even more interestingly, the HA-H110Y mutation
detected in the ferret-transmissible virus isolated by Herfst et al.
(2012) was also shown recently to increase heat stability (Linster
et al., 2014; de Vries et al., 2014). Together, these ﬁndings suggest
that the acquisition of human-type receptor-binding speciﬁcity
results in an unfavorable change in HA stability that requires
compensatory mutations to offset the reduction in virus ﬁtness.
Two independent studies thus found the same mechanistic expla-
nation for amino acid changes in HA, indicating that receptor-
binding speciﬁcity and HA stability/fusion are mechanistically
linked to determine virus transmissibility.
To date, more than 70 mutations in H1, H2, H3, H5, and H7 HA
proteins have been described that affect HA heat stability and the
pH at which fusion occurs (reviewed in (Russell, 2014)). The K387I
mutation in an H5 HA reduced the pH value at which the
conformational change occurred (Reed et al., 2009) and attenuated
H5N1 virus replication in ducks (Reed et al., 2010). However, this
mutation enhanced virus replication in mice (Zaraket et al., 2013)
and in the upper respiratory tract of ferrets (Zaraket et al., 2013).
Another study demonstrated that higher pH optima for the HA
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conformational change (in the range of pH 5.2–6.0) correlated
with increased virulence in avian species (DuBois et al., 2011).
Collectively, these ﬁndings established that avian and human
inﬂuenza viruses have different pH optima for fusion, and that
adapting changes which affect HA stability and the pH optimum
for fusion may be critical to facilitate virus transmission and the
establishment of new lineages.
The role of NA in inﬂuenza A virus transmission
The NA protein encodes a sialidase that cleaves sialic acids from
sialyloligosaccharides; this enzymatic activity is vital for efﬁcient
infection and release of viruses from host cells, as the virus would
otherwise be trapped by sialic acids on mucus or remain attached
to the sialic acids on the host cells, resulting in large viral
aggregates. HA-mediated binding to, and NA-mediated release
from sialic acids therefore must be balanced for efﬁcient virus
replication. The NA proteins of all inﬂuenza viruses exhibit
signiﬁcantly higher enzymatic activity against Siaα2,3Gal than
against Siaα2,6Gal (Baum and Paulson, 1991; Kobasa et al., 1999;
Garcia et al., 2014); nonetheless, the N1 NA of a 2009 pandemic
virus had detectable activity against Siaα2,6Gal (Garcia et al.,
2014), similar to NA proteins derived from human N2 viruses
(Baum and Paulson, 1991; Kobasa et al., 1999). Interestingly,
several of the recently identiﬁed respiratory droplet-trans-
missible H5 viruses possess an NA gene derived from a human
N2 virus (Chen et al., 2012) or from a 2009 pandemic H1N1 virus
(Imai et al., 2012; Zhang et al., 2013). Replacement of the N2 NA
gene of an H1N2 swine virus (which differed from the 2009
pandemic H1N1 virus by only the NA vRNA segment) with the
2009 pandemic H1N1 NA gene increased virus transmission by
respiratory droplet transmission in ferrets (Yen et al., 2011). In
contrast, Zhang et al. (2013) and Herfst et al. (2012) identiﬁed
respiratory droplet-transmissible H5 viruses possessing the avian
virus NA vRNA segment, demonstrating that a human virus NA
vRNA segment is not essential for respiratory droplet transmissi-
bility in mammals.
NA proteins may possess in-frame deletions that result in
‘stalks’ of different lengths (the stalk anchors the NA globular
head, including the enzymatic center, to the virus membrane). In
particular, a 20-amino acid deletion has been prevalent in the stalk
of H5N1 virus NA proteins since 2003. The length of the NA stalk
affects inﬂuenza virulence (Zhou et al., 2009; Munier et al., 2010)
and may facilitate the adaptation of avian inﬂuenza viruses to
terrestrial poultry (Guan et al., 2004; Banks et al., 2001; Campitelli
et al., 2004; Giannecchini et al., 2006; Li et al., 2011; Yamada et al.,
2012). Two 2009 pandemic H1N1 viruses encoding H5N1 virus-
derived NA proteins with long or short stalks transmitted to ferrets
in the same cage, but only the virus encoding the NA with the long
stalk also transmitted via respiratory droplets (Blumenkrantz et al.,
2013). The transmissible virus had higher neuraminidase activity
(Blumenkrantz et al., 2013), which may have facilitated its release
from host cells and its transmission to ferrets housed in adjacent
cages. These ﬁndings suggest that the length of the NA stalk may
contribute to inﬂuenza virus transmission.
The role of polymerase proteins in inﬂuenza A virus
transmission
Inﬂuenza viral replication and transcription are catalyzed by
the viral polymerase complex, composed of the PB2, PB1, and PA
proteins. Although all three polymerase subunits affect inﬂuenza
virulence, PB2 is the main polymerase determinant for inﬂuenza
virulence and host range and thus, for inﬂuenza virus adaptation
to new hosts. Studies by Subbarao et al. (1993) and Hatta et al.
(2001) found that the amino acid at position 627 of PB2 is critical
for efﬁcient inﬂuenza virus replication in mammalian cells. Most
human inﬂuenza viruses (with the exception of 2009 pandemic
H1N1 viruses, see below) encode a lysine at this position, which
confers efﬁcient viral replication in the upper respiratory tract of
mammals (Hatta et al., 2007). A glutamic acid residue at PB2-627
(encoded by most avian virus PB2 proteins) restricts virus replica-
tion in mammals, particularly at 33 1C (i.e., the temperature of the
upper respiratory tract) (Hatta et al., 2007). The PB2 proteins of the
1918, 1957, 1968, and 1977 pandemic viruses are from the same
PB2 ‘lineage’ and all encode PB2-627K. In 2005, highly pathogenic
avian H5N1 viruses caused an outbreak among several avian
species at Qinghai Lake, China (Chen et al., 2005, 2006; Liu et al.,
2005). In some of these viruses, the PB2-627K mutation emerged,
and descendants of these viruses have spread westward into
Europe and the Middle East, so that all contemporary Middle
Eastern H5N1 viruses encode the mammalian-adapting PB2-627K
residue. Moreover, PB2-627K is frequently selected during the
replication of avian inﬂuenza viruses not only in humans and other
mammals, but also in poultry (reviewed in (Wright et al., 2013)).
Together, these ﬁndings established the signiﬁcance of PB2-627K
for inﬂuenza virus adaptation to new hosts.
The 2009 pandemic H1N1 PB2 proteins encode PB2-627E (i.e.,
the avian-type amino acid). However, a basic residue at PB2
position 591 (in the three-dimensional structure located close to
position 627) was shown to compensate for the lack of PB2-627K
(Mehle and Doudna, 2009; Yamada et al., 2010). Other residues in
PB2 also affect virulence and host range. An aspartic acid (encoded
by most avian inﬂuenza viruses) to asparagine change at position
701 increased the virulence of avian inﬂuenza viruses in mammals
(Li et al., 2005; Gabriel et al., 2005). The amino acid at position
PB2-701 interacts with the cellular nuclear import factor importin
α; asparagine facilitates a stronger interaction with importin α in
mammalian cells relative to avian cells, resulting in increased
replicative ability (Gabriel et al., 2008). The aspartic acid-to-
asparagine change has been detected upon replication of avian
inﬂuenza viruses in humans, other mammals, and ostriches (see
Inﬂuenza Research Database at www.ﬂudb.org), underscoring the
role of this mutation for inﬂuenza virus adaptation to novel hosts.
In addition, the amino acid at position 271 of PB2 affects the
replicative ability of inﬂuenza viruses: PB2-271A (found in most
human inﬂuenza viruses) confers higher replication in mammalian
cells and mice than does PB2-271T (typically found in avian
inﬂuenza viruses) (Bussey et al., 2010).
The role of PB2 in inﬂuenza virus transmissibility was estab-
lished in several studies: one experiment demonstrated that the
HA and NA genes of the 1918 pandemic virus did not confer
respiratory droplet transmission to an avian inﬂuenza virus in
ferrets, but the addition of the 1918 pandemic virus PB2 gene
conferred this ability (Van Hoeven et al., 2009). Specially, the
human-type PB2-627K and/or -701N residues conferred higher
virus transmissibility in guinea pigs in the genetic background of
an H5N1 (Steel et al., 2009; Gao et al., 2009) or human H3N2 (Steel
et al., 2009) viruses. Another study found that an HA-Q226R or a
PB2-A271T mutation in a 2009 pandemic H1N1 virus abolished
respiratory droplet transmission in guinea pigs, and that both
mutations together abolished respiratory droplet transmission in
ferrets (Zhang et al., 2012). The partially transmissible H5 virus
described by Chen et al. (2012) did not encode a human-type
amino acid at PB2-627, -701, -or 271, suggesting that limited H5
virus transmission in guinea pigs can be achieved without these
amino acid markers in PB2. By contrast, the ferret-transmissible
H5 viruses isolated by Herfst et al. (2012) and Imai et al. (2012)
possessed the intentionally introduced PB2-627K mutation or the
PB2 gene of a 2009 pandemic H1N1 virus (hence encoding a basic
G. Neumann, Y. Kawaoka / Virology 479-480 (2015) 234–246240
residue at position 591), respectively. In another study, Zhang et al.
(2013) reported that the PA or NS vRNA segment of a human virus
was sufﬁcient to render an avian H5N1 virus respiratory droplet
transmissible in guinea pigs; interestingly, the avian H5N1 virus
used in this study (A/duck/Guanxi/35/2001) encodes the human-
adapting PB1-701N residue.
The recent publications of the X-ray crystallographic structures
of inﬂuenza A and B virus polymerase complexes (Pﬂug et al.,
2014; Reich et al., 2014) allow this structural information to be
correlated with amino acid residues that affect replicative ability,
virulence, and host range. We mapped mutations known to affect
inﬂuenza viral replicative ability onto the structure and, in addi-
tion to the known ‘627 domain’, identiﬁed an area in which several
of the amino acids that affect replication are located (Fig. 1):
Position 339, which is involved in cap-binding (Liu et al., 2013) and
affects virulence (Liu et al., 2013; Fan et al., 2014; Yamaji et al.,
2015); position 253, which affects the polymerase activity of an H9
virus polymerase complex (Mok et al., 2011); position 256, which
affects the polymerase activity of an avian H5N1 inﬂuenza virus
(Manzoor et al., 2009); and position 526 which, together with
other positions in PB2, affects H5N1 viral polymerase activity
(Leung et al., 2010). Based on their location, the amino acid
residues at these positions may interact with a common factor,
such as the cap structure of mRNAs or a host protein.
The role of the ‘triple reassortant internal gene’ cassette in
inﬂuenza A virus transmission
Viruses with the ‘triple reassortant internal genes’ that
emerged in North American swine viruses in 1998 replaced the
classical H1N1 swine viruses in North America that had circulated
for six decades, attesting to the ability of viruses with these genes
to establish a new lineage, and to replace the previously circulat-
ing one. As brieﬂy described in the section on ‘Establishment of
Novel Inﬂuenza A Virus Lineages in Humans’, these viruses possess
the following segments: PB2 and PA polymerase vRNA segments
derived from avian inﬂuenza viruses; nucleoprotein (NP), matrix
(M), and nonstructural (NS) vRNA segments derived from pre-
viously circulating H1N1 swine inﬂuenza viruses; and HA, NA, and
PB1 vRNA segments derived from human inﬂuenza viruses
(Karasin et al., 2000; Olsen, 2002; Webby et al., 2000; Zhou
et al., 1999). The transmissibility of these viruses in ferrets was
found to depend primarily on the origin of the HA and NA genes
(Belser et al., 2011; Barman et al., 2012; Pascua et al., 2012);
however, the polymerase PB2, PB1, and PA genes also affected
transmissibility (Pascua et al., 2012).
The 2009 pandemic H1N1 viruses differ from some of the
North American triple reassortant swine viruses in the origin of
their NA and M vRNA segments (see ‘Establishment of Novel
Inﬂuenza Virus Lineages in Humans’). While 2009 pandemic
H1N1 viruses transmit efﬁciently among ferrets via respiratory
droplets (reviewed in (Neumann et al., 2009; Wright et al., 2013)),
a reassortant possessing the NA and M vRNA segments of a North
American triple reassortant swine virus isolated from an infected
person (A/Ohio/02/2007) did not transmit to all exposed ferrets
(Lakdawala et al., 2011). This ﬁnding suggested that the Eurasian
avian-like swine virus NA and M vRNA segments of 2009 pan-
demic H1N1 viruses may contribute to the transmissibility of these
viruses, at least in the ferret model. Other studies demonstrated
that A/Puerto Rico/8/34 (H1N1, a strain commonly used in inﬂu-
enza virus research) does not transmit via respiratory droplets
Fig. 1. Location of the PB2 residues 253, 256, 339, and 526, which affect viral replication. Shown is the three-dimensional structure of an inﬂuenza A virus polymerase
complex (Protein Data Bank ID 4WSB). The PB2, PB1, and PA subunits are shown in gold, blue, and gray, respectively. PB2 residues 253, 256, 339, and 526 are indicated in
blue, red, green, and orange, respectively. (A) Surface view. (B) ‘Ribbon view’ to depict α-helices and β-sheets. Amino acid spheres are shown for PB2 residues 253, 256, 339,
and 526. (C) Enlarged view of (B).
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among guinea pigs; however, PR8 reassortant viruses possessing
the 2009 pandemic H1N1 HA, NA, and M vRNA segments
(Campbell et al., 2014) or the 2009 pandemic H1N1 M vRNA
segment (Chou et al., 2011) were transmitted among subsets of
guinea pigs via direct contact or respiratory droplets, respectively.
Likewise, the 2009 pandemic H1N1 M vRNA segment increased
the transmissibility of a triple reassortant swine virus that pos-
sessed the 2009 pandemic H1N1 HA and NA genes (Chou et al.,
2011). These ﬁnding are consistent with a study that demonstrated
the importance of the 2009 pandemic H1N1 HA and M genes for
virus replication and transmissibility in pigs (Ma et al., 2012).
Collectively, these studies suggest that the 2009 pandemic H1N1
NA and M vRNA segments are important for the transmissibility of
2009 pandemic H1N1 viruses. The importance of the NA segments
may stem from its ability to confer relatively high neuraminidase
activity and efﬁcient particle release from infected cells
(Lakdawala et al., 2011; Campbell et al., 2014).
Conclusion
Recent studies have demonstrated that avian inﬂuenza viruses
of different subtypes may acquire the ability to transmit among
mammals. Several features including HA receptor-binding speciﬁ-
city, HA stability, HA glycosylation, and viral replicative ability in
mammalian cells likely act together to allow avian inﬂuenza
viruses to adapt to, replicate in, and transmit among mammals.
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